The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
PrEP Stigma: Implicit and Explicit Drivers of Disparity
Open accessAbstract
Purpose of review Despite its promise as an HIV prevention strategy, PrEP uptake remains slow, especially among highest priority populations. One factor that may be impeding implementation and driving disparities is PrEP-related stigma. This paper reviews the role of PrEP-related stigma in PrEP access, adherence, and persistence and examines its antecedents and consequences. Recent findings Although PrEP stigma is often experienced at the community level (i.e., by potential and current users), it can be reinforced and even amplified by public health programs, policy, and research. PrEP stigma disproportionately impacts disadvantaged groups and impedes scalability by influencing behavior of both patients and providers. Reducing PrEP stigma and its negative impact on the epidemic requires a significant shift in perspective, language, and programs. Such a shift is necessary to ensure broader reach of PrEP as a prevention strategy and improve its utilization by the individuals who need it most.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In terms of health domains, HIV/AIDS accounted for 40% of included studies, consistent with prior reviews (112).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [112]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stigma: Notes on the Management of Spoiled Identity
(1969) · Postgraduate Medical Journal · doi:10.1136/pgmj.45.527.642 · Cited by 14,255
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapía, M., Montoya, O., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004006 · Cited by 1,054
Fear appeals in social marketing: Strategic and ethical reasons for concern
Hastings, G., Stead, M., & Webb, J. (2004) · Psychology and Marketing · doi:10.1002/mar.20043 · Cited by 595
Sullivan, P. S., Salazar, L. F., Buchbinder, S., & Sanchez, T. (2009) · AIDS · doi:10.1097/qad.0b013e32832baa34 · Cited by 559
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
Identifying Individuals at High Risk for Diabetes
Schmidt, M. I., Duncan, B. B., Bang, H., Pankow, J. S., Ballantyne, C. M., Golden, S. H., Folsom, A. R., Chambless, L. E., & for the Atherosclerosis Risk in Communities Investigators (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2013 · Cited by 455
Lifetime risk of a diagnosis of HIV infection in the United States
Hess, K. L., Hu, X., Lansky, A., Mermin, J., & Hall, H. I. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.02.003 · Cited by 356
Smith, D. K., Handel, M. M. V., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., Koenig, L. J., & Valleroy, L. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6446a4 · Cited by 355
Calabrese, S. K., & Underhill, K. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302816 · Cited by 329
Research works printed but not linked: 1
- Joint United Nations Programme on HIV/AIDS (UNAIDS). On the Fast-Track to end AIDS by 2030: Focus on location and population. Geneva: UNAIDS; 2015.
Cited by
Sorted by citations
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Mayer, K. H., Agwu, A. L., & Malebranche, D. J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01295-0 · Cited by 438
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses
Sullivan, P. S., Johnson, A. S., Pembleton, E. S., Stephenson, R. B., Justice, A. C., Althoff, K. N., Bradley, H. M., Castel, A. D., Oster, A. M., Rosenberg, E. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00395-0 · Cited by 366
Quinn, K. G., Dickson‐Gómez, J., Zarwell, M., Pearson, B., & Lewis, M. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2375-z · Cited by 240
Implementation Strategies to Increase PrEP Uptake in the South
Sullivan, P. S., Mena, L. A., Elopre, L. E., & Siegler, A. J. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00447-4 · Cited by 240
Velloza, J., Khoza, N., Scorgie, F., Chitukuta, M., Mutero, P., Mutiti, K. S., Mangxilana, N. T., Nobula, L., Bulterys, M. A., Atujuna, M., et al. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25463 · Cited by 225
Metadata
- Authors
- Golub, S. A.
- Affiliations
- The Graduate Center, CUNY (US)
- Corresponding author
- Golub, Sarit A.
- ORCID
- Golub, Sarit A.
- Venue
- Current HIV/AIDS Reports
- Published
- 2018-02-19
- Volume
- 15
- Issue
- 2
- Pages
- 190-197
- ISSN
- 1548-3568 (ISSN-L)
- 1548-3576
- PMC
- PMC5884731
- OpenAlex
- W2792635178
- Cited by
- 383
- References
- 67
- Citations by year
- 2026: 47 · 2025: 56 · 2024: 52 · 2023: 50 · 2022: 51 · 2021: 63 · 2020: 39 · 2019: 21 · 2018: 4
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current HIV/AIDS Reports (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Gilead Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV PrEP, PrEP stigma, HIV prevention, PrEP uptake, health disparities, PrEP adherence, PrEP persistence, HIV prevention programs, HIV prevention policy, HIV prevention research, provider behavior, community stigma
- MeSH terms
- Humans, Male, HIV Infections, Anti-HIV Agents, Social Stigma, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
